Track the 삼일제약 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 삼일제약 has recorded 56 public disclosures. The latest transaction was reported on 1 July 2026 (Purchase). Among the most active insiders: 허승범. Every trade is free.
55
Insider Decl.
n/a
Thresholds
n/a
35 ops.
Buy Volume
n/a
16 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
삼일제약 es una empresa de salud y farmacéutica que cotiza en el mercado XKRX. Se especializa en la investigación, el desarrollo y la comercialización de productos farmacéuticos.